Nabriva Therapeutics plc (NASDAQ:NBRV – Get Free Report) shares crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Nabriva Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com started coverage on Nabriva Therapeutics in a report on Friday. They issued a “hold” rating for the company.
Check Out Our Latest Report on Nabriva Therapeutics
Nabriva Therapeutics Stock Down 100.0 %
Nabriva Therapeutics Company Profile
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration.
Read More
- Five stocks we like better than Nabriva Therapeutics
- What Are Dividends? Buy the Best Dividend Stocks
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What is the Nasdaq? Complete Overview with History
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Nabriva Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nabriva Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
